Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mid-trial design reviews for sequential clinical trials.

J Whitehead1, A Whitehead, S Todd

  • 1Medical and Pharmaceutical Statistics Research Unit, The University of Reading, P.O. Box 240, Earley Gate, Reading RG6 6FN, UK.

Statistics in Medicine
|February 13, 2001
PubMed
Summary

Sequential clinical trials guarantee power by analyzing treatment differences against information, irrespective of nuisance parameters. Mid-trial design reviews are crucial for optimizing sample size and information, especially in trials with normal responses and distinct recruitment/follow-up phases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rurality, Deprivation and Ethnicity in New Zealand: Population Distributions and Intersecting Impacts on Mortality.

The Australian journal of rural health·2026
Same author

The multifaceted implications of mental fatigue on women's football players' performance in small-sided games.

Psychology of sport and exercise·2025
Same author

Expanding the all-hazards approach to include extreme cold weather: optimising emergency medical care.

BMJ military health·2025
Same author

Stressors faced by forcibly displaced Ukrainians in England within 6 months of arrival: A qualitative study.

Social science & medicine (1982)·2025
Same author

Oncocytic papillary cystadenoma.

British dental journal·2024
Same author

Experiences of UK and Irish family carers of people with profound and multiple intellectual disabilities during the COVID-19 pandemic.

BMC public health·2023

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Statistical Power Analysis

Background:

  • Sequential clinical trials offer guaranteed statistical power by analyzing treatment differences against accumulated information.
  • Nuisance parameters necessitate assigning specific values for sample size distribution estimations.
  • Interim analyses present opportunities to reassess the interplay between sample size and information.

Purpose of the Study:

  • To discuss the utility and implementation of mid-trial design reviews in sequential clinical trials.
  • To highlight the particular importance of these reviews in specific trial designs and response distributions.
  • To demonstrate the validity of the proposed review procedure through simulations.

Main Methods:

  • The study involves plotting statistics measuring treatment difference against those measuring information.

Related Experiment Videos

  • It discusses mid-trial design reviews as a method for re-evaluating sample size and information.
  • Extensive simulations are used to validate the review procedure for normally distributed responses.

    • Main Results:

    • Mid-trial design reviews allow for the re-evaluation of sample size and information during sequential trials.
    • These reviews are especially critical for trials with a short recruitment phase followed by extended follow-up.
    • The review procedure is demonstrated as valid for normally distributed responses via simulations.

    Conclusions:

    • Mid-trial design reviews are a valuable tool for adaptive clinical trial management.
    • Optimizing sample size and information through interim reviews enhances trial efficiency and power.
    • The discussed methodology is robust, particularly for normally distributed outcomes.